Surgery Partners Quarterly Cash Flow Statement
NASDAQ: SGRYHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Surgery Partners free cash flow
In the quarter ended Jun 30, 2026, Surgery Partners generated $59.3 million of operating cash flow and spent $21.8 million on capital expenditures. That left free cash flow of $37.5 million, a free-cash-flow margin of 4.4% of revenue. Free cash flow was down 35.2% from the prior year's $57.9 million.
Summary generated from market data by MetaCap's automated system. Methodology
Surgery Partners cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 29.70M | -2.10M | 29.00M | 25.30M | 44.90M | -300.00K | -46.60M | 6.40M | 28.40M | 24.30M | 46.70M | 29.70M |
| Net Income growth (YoY) | -33.85% | — | — | +295.31% | +58.10% | -101.23% | -199.79% | -78.45% | -50.78% | +1925.00% | +100.43% | +430.36% |
| Depreciation & Amortization | 39.30M | 38.50M | 59.90M | 39.50M | 40.30M | 36.30M | 33.90M | 50.20M | 34.80M | 33.70M | 31.10M | 28.90M |
| Stock-Based Compensation | 3.80M | 5.80M | -2.20M | 2.60M | 6.80M | 7.60M | 6.20M | 7.10M | 15.10M | 4.90M | 4.50M | 4.40M |
| Change in Working Capital | -15.00M | 3.60M | -46.10M | -16.20M | 3.70M | 4.80M | -40.90M | -19.10M | -17.50M | 5.40M | -29.00M | -13.10M |
| Operating Cash Flow | 59.30M | 11.70M | 103.40M | 83.60M | 81.30M | 6.00M | 111.40M | 65.20M | 82.80M | 40.70M | 62.60M | 104.60M |
| Capital Expenditures | -21.80M | -16.00M | -12.80M | -19.80M | -23.40M | -22.70M | -22.30M | -20.20M | -26.90M | -21.00M | -19.80M | -18.90M |
| Investing Cash Flow | -19.80M | -13.40M | -126.10M | -46.20M | 2.10M | -76.40M | -111.70M | -49.60M | -244.10M | -83.10M | -58.10M | -25.60M |
| Debt Issued | 154.60M | 195.40M | 692.50M | 127.90M | 168.60M | 213.60M | 265.90M | 168.40M | 1.10B | 192.50M | 707.20M | 92.90M |
| Debt Repaid | -116.40M | -193.80M | -579.40M | -161.00M | -180.10M | -119.30M | -170.50M | -135.00M | -853.60M | -120.20M | -700.00M | -75.60M |
| Financing Cash Flow | -5.10M | -55.90M | 59.20M | -84.10M | -62.60M | 30.20M | 48.00M | -7.30M | 189.60M | 31.70M | -44.60M | -20.40M |
| Net Change in Cash | 34.40M | -57.60M | 36.50M | -46.70M | 20.80M | -40.20M | 47.70M | 8.30M | 28.30M | -10.70M | -40.10M | 58.60M |
| Free Cash Flow | 37.50M | -4.30M | 90.60M | 63.80M | 57.90M | -16.70M | 89.10M | 45.00M | 55.90M | 19.70M | 42.80M | 85.70M |
This table shows 12 quarterly periods of Surgery Partners's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SGRY's reporting calendar. What is a cash flow statement?